Financial Daily from THE HINDU group of publications
Friday, Oct 22, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Industry & Economy - Bio-tech & Genetics


New biz model for biotech soon

Our Bureau


(From left) The Chairman and MD, Biocon Ltd, Ms KIran Mazumdar-Shaw, the Union Minister for Science and Technology, Mr Kapil Sibal, and the Minister for Industries and Infrastructure, Karnataka Government, Mr P.G.R. Sindhia, at the inauguration of Syngene's new research facility at Bommasandra in Bangalore on Thursday. — G.R.N. Somashekar

Bangalore , Oct. 21

THE Centre is scripting a "win-win" business model for the fledgling biotechnology industry so that the fund-starved sector can enter into equity-based partnerships with Government agencies.

This will help biotech companies to avoid dependence on grants and financial support from the Government, while getting free access to technology.

The Union Minister for Science & Technology, Mr Kapil Sibal, assured industry representatives here that his Ministry was drafting such a plan in public-private partnership (PPP). With all its risks, a PPP, he said, was a viable way for enterprises to thrive. The Government through its agency would pick equity in the joint venture that the company would float. In turn, the enterprise would get technology transferred free of charge from a public lab. Profits from successful venture would be ploughed back into further research projects.

Mr Sibal was briefing the media after an interaction with the members of the biotech industry. He said the industry mainly raised issues related to duty anomalies, funding, intellectual property and regulations.

All these would be addressed in the National Biotechnology Policy that the Department of Biotechnology was working on. The policy framework would be announced in January 2005. The policy would also draw suitable inputs from the report that the Swaminathan task force report on agri biotech has submitted and the Mashelkar report that is coming out shortly on DNA drugs.

The DBT Secretary, Mr M.K.Bhan, had announced the plan for such a policy during the Bangalore Bio conference held in July.

The new WTO-compliant Patents Act would also be in place by January 2005 and would take care of the IP issues of the knowledge-based industry. "The Government will not violate its international commitments," he said.

At the same time, a Bioinformatics Policy, the first in the world, was also in the making and would be announced around May 2005. The first draft was ready and consultations were on among the IT, communications and S&T Ministries.

All these measures would attract huge amounts of FDI into the nearly $ 1-billion domestic biotech sector and make it a $ 10-billion global industry.

Mr Sibal said his Ministry found it difficult to approve proposals like a biotech seed capital fund. He recalled that a well-meaning move for a drug development fund got whittled down from Rs 500 crore to just the interest on a corpus of Rs 25 crore. "The PPP model will be such that we do not have to go the Finance Ministry every day."

However, a good PPP calls for synergy among the activities of the four elements - academia, labs, government agencies and the entrepreneur.

The Ministry planned to tackle the long procedural and regulatory delays in approvals for biotech products through a single-window mechanism. It was also looking at a need to have "at least 20 more Indian Institutes of Science" to address the emerging HR needs of the industry.

The diagnostics sector raised the problem of import duty anomaly, where the indigenous kit manufacturer paid 16 per cent import duty for raw materials, while whole kit imports had no duty. Mr Sibal said this would be taken up with the Finance Ministry. He hoped to get the biotech sector the same incentives that the IT industries enjoy.

The interaction was organised by ABLE - the Association of Biotechnology-Led Enterprises. ABLE represents some 90 companies across the country.

More Stories on : Bio-tech & Genetics

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Israel for bilateral ties in IT, biotech fields


Meet on trade with Europe in Hyderabad
Workshop on cervical cancer in Hyderabad
SEZ project will continue in Mangalore: CM
Restructuring plan for Kerala PSUs under review
ISO certification for ONGC plant
New technology to detect fake drugs
Appellate tribunal for electricity soon
Panel on small hydro power
Steel alliance urges Govt to adopt long-term policy framework
PHDCCI opposes cess on turnover
Call to protect Kerala water sources
Prasar Bharati to have more `narrow casting' centres
Ranjit Sen is new IACC President
New biz model for biotech soon
Bengal Postal Circle to earn Rs 330 cr via small savings
Sale of second-hand capital goods — Norms eased for export units in DTA
Strikes won't achieve much: INTUC chief
ICAI advises members to adhere to Oct 31 deadline for returns
Low orthodox output may hamper tea exports
UltraTech Cement to step up exports
TN: 38 towns are heritage cities



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright � 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line